Sites of action of novel treatments for GH. CD40L, CD40 ligand; GH, Graves' hyperthyroidism; MAb, monoclonal antibody; MHC Class II, major histocompatibility complex class II molecule; TSH-R, thyrotropin receptor; TSI, thyroid-stimulating immunoglobulin.